3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
3
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
18
Hematologic Neoplasms
14
Leukemia
13
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Uterine Cervical Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Breast Neoplasms
2
Blast Crisis
2
Virus Diseases
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Recurrence
1
Pyruvate Kinase Deficiency of Red Cells
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Interventions
Cyclophosphamide
72
Cytarabine
61
fludarabine phosphate
48
venetoclax
41
Peripheral Blood Stem Cell Transplantation
37
fludarabine
34
Busulfan
31
Methotrexate
29
Cyclosporine
29
Mycophenolic Acid
28
Filgrastim
27
Azacitidine
27
Antilymphocyte Serum
26
Whole-Body Irradiation
22
Etoposide
21
Radiotherapy
20
Melphalan
20
Tacrolimus
19
Rituximab
19
Dexamethasone
16
Methylprednisolone
15
Granulocyte Colony-Stimulating Factor
15
Decitabine
15
Vincristine
14
Cord Blood Stem Cell Transplantation
14
Doxorubicin
13
Clofarabine
11
Mitoxantrone
10
ibrutinib
9
blinatumomab
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Blood Specimen Collection
×
Other hematologic neoplasm
×
Clear all
NCT07570407
2026-05-06
QiNKT-HSCT
University Hospital Pilsen
Not yet recruiting
75 enrolled